EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Possible therapeutic effect of frankincense (Gum olibanum) and myrrh (Commiphora myrrha) resins extracts on DEN/CCL4 induced hepatocellular carcinoma in rats

Amira M. Elmoslemany, Mohamed Elzallat, Mai Hussein Abd-Elfatah, Dina Mostafa Mohammed, Eman E.Abd Elhady

Phytomedicine Plus · 2024-02 · 4 (1) · 100517

DOI: 10.1016/j.phyplu.2023.100517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine Plus, 2024-02. Verfasst von Amira M. Elmoslemany und 4 weiteren Autor:innen. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Liver cancer is a prominent global health concern characterized by prevalent and unregulated exposure to ubiquitous environmental hazards. Phytochemicals, naturally occurring molecules derived from plants, possess inherent qualities that exhibit anticancer effects. Numerous in vitro studies have investigated the potential impact of combining frankincense and myrrh on hepatocellular cancer. However, it is noteworthy that these investigations have yet to be extended to in vivo studies.

Purpose

This research aimed to evaluate the consequences of frankincense and myrrh, individually and in combination, on the progression and development of hepatocellular carcinoma in vivo.

Methods

Forty-two male Sprague-Dawley rats were selected for this research, and thirty-six rats were subjected to intraperitoneal administration of DEN/CCL4. Growth-related parameters, inflammatory cytokines, lipid peroxidation, non-enzymatic and enzymatic antioxidants, hepatic function biomarkers, protein fractions, histopathological examination, and gene expression were evaluated.

Results

The results showed that frankincense extract (group 2) (500 mg/kg) and myrrh extract (group 4) (500 mg/kg) significantly improved histopathological and biochemical assessments. The combination of both frankincense extract (250 mg/kg) and myrrh extract (250 mg/kg) (group 5) showed the best results in growth-related parameters, biochemical parameters, and histopathological examination. It also inhibited liver cancer cells' movement and invasion and blocked EMT occurrence via suppressing the signaling of the Wnt/β-catenin pathway (B-catenin: 1.44 ± 0.06; PCNA: 1.40 ± 0.08; and Cyclin D1: 1.32 ± 0.13).

Conclusion

The growth-related parameters, biochemical parameters, histopathological examination, and gene expression confirmed that frankincense extract, myrrh extract, or their combination had a potential therapeutic effect with promising prospects for managing hepatocellular carcinoma (HCC).

Zitieren

APA

Elmoslemany, A. M., Elzallat, M., Abd-Elfatah, M. H., Mohammed, D. M., & Elhady, E. E. (2024). Possible therapeutic effect of frankincense (Gum olibanum) and myrrh (Commiphora myrrha) resins extracts on DEN/CCL4 induced hepatocellular carcinoma in rats. Phytomedicine Plus, 4(1), 100517. https://doi.org/10.1016/j.phyplu.2023.100517

Vancouver

Elmoslemany AM, Elzallat M, Abd-Elfatah MH, Mohammed DM, Elhady EE. Possible therapeutic effect of frankincense (Gum olibanum) and myrrh (Commiphora myrrha) resins extracts on DEN/CCL4 induced hepatocellular carcinoma in rats. Phytomedicine Plus. 2024;4(1):100517. doi:10.1016/j.phyplu.2023.100517

BibTeX
@article{Elmoslemany2024,
  author = {Elmoslemany, Amira M. and Elzallat, Mohamed and Abd-Elfatah, Mai Hussein and Mohammed, Dina Mostafa and Elhady, Eman E.Abd},
  title = {Possible therapeutic effect of frankincense (Gum olibanum) and myrrh (Commiphora myrrha) resins extracts on DEN/CCL4 induced hepatocellular carcinoma in rats},
  journal = {Phytomedicine Plus},
  year = {2024},
  volume = {4},
  number = {1},
  pages = {100517},
  doi = {10.1016/j.phyplu.2023.100517}
}
Kostenlos starten →